MGAT5/TMEM163 variant is associated with prognosis in ursodeoxycholic acid-treated patients with primary biliary cholangitis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MGAT5/TMEM163 variant is associated with prognosis in ursodeoxycholic acid-treated patients with primary biliary cholangitis
Authors
Keywords
-
Journal
JOURNAL OF GASTROENTEROLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-17
DOI
10.1007/s00535-023-02045-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis
- (2022) Christophe Corpechot et al. JOURNAL OF HEPATOLOGY
- Prediction and evaluation of high-risk patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy: an early criterion
- (2022) Chunmei Yang et al. Hepatology International
- A zinc transporter, transmembrane protein 163 (TMEM163), is critical for the biogenesis of platelet dense granules
- (2021) Yefeng Yuan et al. BLOOD
- An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs
- (2021) Heather J. Cordell et al. JOURNAL OF HEPATOLOGY
- TMEM163 Regulates ATP-Gated P2X Receptor and Behavior
- (2020) Elizabeth J. Salm et al. Cell Reports
- Primary biliary cholangitis
- (2020) Ana Lleo et al. LANCET
- Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores
- (2020) Cristiana Bianco et al. JOURNAL OF HEPATOLOGY
- Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis
- (2019) Maren H. Harms et al. JOURNAL OF HEPATOLOGY
- Validation of Risk Scoring Systems in Ursodeoxycholic Acid–Treated Patients With Primary Biliary Cholangitis
- (2019) Cumali Efe et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response
- (2019) Carla F. Murillo Perez et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Transmembrane 163 (TMEM163) protein effluxes zinc
- (2019) Vanessa B. Sanchez et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Role of Tmem163 in zinc-regulated insulin storage of MIN6 cells: Functional exploration of an Indian type 2 diabetes GWAS associated gene
- (2019) Shraddha Chakraborty et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
- (2019) Mike A Nalls et al. LANCET NEUROLOGY
- Primary biliary cholangitis: pathogenesis and therapeutic opportunities
- (2019) Aliya F. Gulamhusein et al. Nature Reviews Gastroenterology & Hepatology
- Current and potential treatments for primary biliary cholangitis
- (2019) Raj A Shah et al. Lancet Gastroenterology & Hepatology
- The Genetics and Epigenetics of Primary Biliary Cholangitis
- (2018) Atsushi Tanaka et al. Clinics in Liver Disease
- Natural History of Primary Biliary Cholangitis in the Ursodeoxycholic Acid Era
- (2018) Aparna Goel et al. Clinics in Liver Disease
- Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases
- (2018) Keith D. Lindor et al. HEPATOLOGY
- Diagnosis and Management of Primary Biliary Cholangitis
- (2018) Zobair M. Younossi et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The fingerprint of antimitochondrial antibodies and the etiology of primary biliary cholangitis
- (2017) Zongwen Shuai et al. HEPATOLOGY
- Autoreactive monoclonal antibodies from patients with primary biliary cholangitis recognize environmental xenobiotics
- (2017) Toshihiro Tanaka et al. HEPATOLOGY
- EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis
- (2017) Gideon M. Hirschfield et al. JOURNAL OF HEPATOLOGY
- Prognostic Factors for Transplant-Free Survival and Validation of Prognostic Models in Chinese Patients with Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid
- (2017) Ka-Shing Cheung et al. Clinical and Translational Gastroenterology
- Genetic Drivers of Epigenetic and Transcriptional Variation in Human Immune Cells
- (2016) Lu Chen et al. CELL
- Zinc and its role in immunity and inflammation
- (2015) Paola Bonaventura et al. AUTOIMMUNITY REVIEWS
- Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy
- (2015) Willem J. Lammers et al. GASTROENTEROLOGY
- The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis
- (2015) Marco Carbone et al. HEPATOLOGY
- A global reference for human genetic variation
- (2015) Richard A. Gibbs et al. NATURE
- The Physiological, Biochemical, and Molecular Roles of Zinc Transporters in Zinc Homeostasis and Metabolism
- (2015) Taiho Kambe et al. PHYSIOLOGICAL REVIEWS
- Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
- (2014) Mike A Nalls et al. NATURE GENETICS
- The Genotype-Tissue Expression (GTEx) project
- (2013) John Lonsdale et al. NATURE GENETICS
- Genome-Wide Association Study for Type 2 Diabetes in Indians Identifies a New Susceptibility Locus at 2q21
- (2012) R. Tabassum et al. DIABETES
- Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcome
- (2011) Christophe Corpechot et al. JOURNAL OF HEPATOLOGY
- Baseline Ductopenia and Treatment Response Predict Long-Term Histological Progression in Primary Biliary Cirrhosis
- (2010) Teru Kumagi et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- American association for the study of liver diseases endpoints conference: Design and endpoints for clinical trials in primary biliary cirrhosis
- (2010) Marina G. Silveira et al. HEPATOLOGY
- Improved Prognosis of Patients With Primary Biliary Cirrhosis That Have a Biochemical Response to Ursodeoxycholic Acid
- (2009) Edith M.M. Kuiper et al. GASTROENTEROLOGY
- Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis
- (2008) Christophe Corpechot et al. HEPATOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started